Cargando…

Meta-analysis with individual data of functional outcomes following Aquablation for lower urinary tract symptoms due to BPH in various prostate anatomies

OBJECTIVES: To evaluate functional outcomes following Aquablation in various prostate volume and anatomical subgroups. DESIGN: A meta-analysis with individual patient data undergoing Aquablation therapy from four prospective, global, clinical studies that have been conducted with Aquablation; WATER,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elterman, Dean, Gilling, Peter, Roehrborn, Claus, Barber, Neil, Misrai, Vincent, Zorn, Kevin C, Bhojani, Naeem, Te, Alexis, Humphreys, Mitch, Kaplan, Steven, Desai, Mihir, Bach, Thorsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749268/ https://www.ncbi.nlm.nih.gov/pubmed/35047807 http://dx.doi.org/10.1136/bmjsit-2021-000090

Ejemplares similares

Transfusion rates after 800 Aquablation procedures using various haemostasis methods
por: Elterman, Dean, et al.
Publicado: (2020)

WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30–80-cm(3) and 80–150-cm(3) Prostates
por: Nguyen, David-Dan, et al.
Publicado: (2021)

Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30–80 and 80–150 mL prostates
por: Nguyen, David‐Dan, et al.
Publicado: (2019)

First Multi-Center All-Comers Study for the Aquablation Procedure
por: Bach, Thorsten, et al.
Publicado: (2020)

Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results
por: Zorn, Kevin C., et al.
Publicado: (2021)

Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained
por: Gilling, Peter, et al.
Publicado: (2019)

Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?
por: Kaplan, Steven A, et al.
Publicado: (2011)

Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH
por: Roehrborn, C G, et al.
Publicado: (2011)

A Standardized Method for Estimating the Carbon Footprint of Disposable Minimally Invasive Surgical Devices: Application in Transurethral Prostate Surgery
por: Misrai, Vincent, et al.
Publicado: (2021)

Integration of aquablation through telemetry: an alternative to onsite proctoring?
por: El-Asmar, Jose M., et al.
Publicado: (2021)

Enterococcal Urinary Tract Infections: A Review of the Pathogenicity, Epidemiology, and Treatment
por: Codelia-Anjum, Alia, et al.
Publicado: (2023)

Patients' Perspectives on Attributes While Choosing Minimally Invasive Surgery for Benign Prostatic Hyperplasia Procedures: Experience from Men Undergoing Water Vapor Thermal Therapy
por: Rojanasarot, Sirikan, et al.
Publicado: (2023)

Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression
por: D’Agate, Salvatore, et al.
Publicado: (2020)

Aquablation for benign prostatic obstruction: Single center technique evolution and experience
por: Labban, Muhieddine, et al.
Publicado: (2021)

Technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation
por: Yee, Chi-Hang, et al.
Publicado: (2022)

Aquablation in men with benign prostate hyperplasia: A systematic review and meta-analysis
por: Chen, David C., et al.
Publicado: (2023)

A Community-Based Education Program for Overactive Bladder in a Predominantly Minority Older Female Population: A Pilot Study
por: Martinez Díaz, Susana, et al.
Publicado: (2022)

Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years – A Review of Published Literature
por: Codelia-Anjum, Alia J, et al.
Publicado: (2023)

Management of BPH then 2000 and now 2016 – From BPH to BPO
por: Braeckman, Johan, et al.
Publicado: (2017)

Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH
por: D’Agate, Salvatore, et al.
Publicado: (2019)

Molecular Breeding of Rice Restorer Lines and Hybrids for Brown Planthopper (BPH) Resistance Using the Bph14 and Bph15 Genes
por: Wang, Hongbo, et al.
Publicado: (2016)

BPH management today
por: Mangera, Altaf, et al.
Publicado: (2014)

Assessment of BPH/BOO
por: Mangera, Altaf, et al.
Publicado: (2014)

Marker assisted pyramiding of Bph6 and Bph9 into elite restorer line 93–11 and development of functional marker for Bph9
por: Wang, Yang, et al.
Publicado: (2017)

Global experience and progress in GreenLight-XPS 180-Watt photoselective vaporization of the prostate
por: Lichy, Isabel, et al.
Publicado: (2022)

PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH
por: Gacci, M., et al.
Publicado: (2013)

Management of the complications of BPH/BOO
por: Speakman, Mark J., et al.
Publicado: (2014)

BPH and prostate cancer risk
por: Miah, Saiful, et al.
Publicado: (2014)

The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)
por: Woo, Henry H., et al.
Publicado: (2022)

Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED
por: Sebastianelli, A., et al.
Publicado: (2020)

Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo‐controlled study
por: Rosen, Raymond C., et al.
Publicado: (2018)

Non-Hormonal treatment of BPH/BOO
por: Osman, Nadir I., et al.
Publicado: (2014)

BPH treatment: laser for everyone | Opinion: NO
por: Almeida, Fernando G., et al.
Publicado: (2018)

Abstract - SUA202 (Endourology/BPH)
Publicado: (2020)

Identification of two QTLs, BPH41 and BPH42, and their respective gene candidates for brown planthopper resistance in rice
por: Tan, Han Qi, et al.
Publicado: (2022)

Resistance to Nilaparvata lugens in rice lines introgressed with the resistance genes Bph14 and Bph15 and related resistance types
por: Han, Yongqiang, et al.
Publicado: (2018)

Marker assisted pyramiding of two brown planthopper resistance genes, Bph3 and Bph27 (t), into elite rice Cultivars
por: Liu, Yanling, et al.
Publicado: (2016)

TURPxit or not: contemporary management options for benign prostatic obstruction
por: Herrmann, Thomas R. W., et al.
Publicado: (2021)

National-wide data on the treatment of BPH in Korea
por: Kang, J Y, et al.
Publicado: (2011)

TURP for BPH. How Large is Too Large?
por: Persu, C, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_n26r0l1aubfp9u9uc03at2gma1